Successful Surgical Treatment of Pediatric FUS :: TFCP2 -Positive Rhabdomyosarcoma of the Mandible: A Case Report
International Journal of Surgical Pathology · 2026
DOI: 10.1177/10668969251414872 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2026. Verfasst von Kohtaro Eguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Mandibular Neoplasms, Rhabdomyosarcoma, DNA-Binding Proteins, RNA-Binding Protein FUS. Die Arbeit nennt 17 Literaturangaben. Gefördert von: the Japan Society for the Promotion of Science (JSPS) KAKENHI.
Abstract (Originalsprache)
FUS :: TFCP2 -positive rhabdomyosarcoma (RMS) is a rare and aggressive subtype that was recently classified as a distinct entity. It is resistant to conventional chemotherapeutic regimens for RMS, and optimal treatment strategies have not been established. Here, we describe an 11-year-old boy with mandibular RMS with a FUS :: TFCP2 fusion gene. At the referring hospital, the patient initially underwent standard induction chemotherapy for RMS, but it was ineffective. Radical resection, including segmental mandibulectomy and reconstruction with a rectus abdominis free flap, was performed. Histological examination of the surgical specimen revealed a viable tumor with minimal response to chemotherapy. The patient had remained disease-free for 18 months. Our experience highlights that early pathological diagnosis and prompt surgical intervention for FUS :: TFCP2 fusion-positive RMS are crucial due to its chemoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, National Cancer Center Hospital, Tokyo, Japan.
- Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Kohtaro Eguchi, Koichi Oshima, Kayoko Tao, Seiichi Yoshimoto
Förderung
- the Japan Society for the Promotion of Science (JSPS) KAKENHI
Zitieren
APA
Eguchi, K., Uchida, E., Oshima, K., Fukuoka, K., Tao, K., Arakawa, A., Fushimi, C., Omura, G., Mori, T., Yoshida, A., Koh, K., & Yoshimoto, S. (2026). Successful Surgical Treatment of Pediatric FUS :: TFCP2 -Positive Rhabdomyosarcoma of the Mandible: A Case Report. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969251414872
Vancouver
Eguchi K, Uchida E, Oshima K, Fukuoka K, Tao K, Arakawa A, et al. Successful Surgical Treatment of Pediatric FUS :: TFCP2 -Positive Rhabdomyosarcoma of the Mandible: A Case Report. International Journal of Surgical Pathology. 2026. doi:10.1177/10668969251414872
BibTeX
@article{Eguchi2026,
author = {Eguchi, Kohtaro and Uchida, Eriko and Oshima, Koichi and Fukuoka, Kohei and Tao, Kayoko and Arakawa, Ayumu and Fushimi, Chihiro and Omura, Go and Mori, Taisuke and Yoshida, Akihiko and Koh, Katsuyoshi and Yoshimoto, Seiichi},
title = {Successful Surgical Treatment of Pediatric FUS :: TFCP2 -Positive Rhabdomyosarcoma of the Mandible: A Case Report},
journal = {International Journal of Surgical Pathology},
year = {2026},
doi = {10.1177/10668969251414872}
}
EUVIMED